KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $4.9 billion.

  • Quest Diagnostics' Treasury Shares rose 346.58% to $4.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year increase of 346.58%. This contributed to the annual value of $4.9 billion for FY2024, which is 64.24% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Treasury Shares is $51.0 million.
  • Over the past 5 years, Quest Diagnostics' Treasury Shares peaked at $95.0 million during Q2 2021, and registered a low of $1.0 million during Q4 2021.
  • Moreover, its 5-year median value for Treasury Shares was $47.5 million (2022), whereas its average is $36.3 million.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 4446.81% in 2021, then surged by 4902.3% in 2022.
  • Over the past 5 years, Quest Diagnostics' Treasury Shares (Quarter) stood at $3.5 billion in 2021, then skyrocketed by 35.33% to $4.7 billion in 2022, then rose by 3.27% to $4.8 billion in 2023, then increased by 0.64% to $4.9 billion in 2024, then rose by 0.8% to $4.9 billion in 2025.
  • Its Treasury Shares was $4.9 billion in Q3 2025, compared to $4.8 billion in Q2 2025 and $4.8 billion in Q1 2025.